James C. Hyde - 10 Feb 2022 Form 4 Insider Report for BALCHEM CORP (BCPC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Feb 2022, 08:04:33 UTC
Next SEC filing
15 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James C. Hyde, by Attorney in Fact, Mark Stach

Key filing fact

James C. Hyde filed Form 4 for BALCHEM CORP (BCPC) on 14 Feb 2022.

Key facts

  • This page summarizes James C. Hyde's Form 4 filing for BALCHEM CORP (BCPC).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Feb 2022, 08:04.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$101,896.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCPC transaction

Common Stock

Award

Transaction value
$0
Shares
+820
Change %
+5.8%
Price
$0.000000
Shares after
14,925
Date
10 Feb 2022
Ownership
Direct
Footnotes
F1
BCPC transaction

Common Stock

Award

Transaction value
$0
Shares
+2,394
Change %
+16%
Price
$0.000000
Shares after
17,319
Date
10 Feb 2022
Ownership
Direct
Footnotes
F2
BCPC transaction

Common Stock

Tax liability

Transaction value
$101,896
Shares
-738
Change %
-4.3%
Price
$138.07*
Shares after
16,581
Date
10 Feb 2022
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCPC transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+2,900
Change %
+7.3%
Price
$0.000000
Shares after
42,360
Date
10 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,900
Exercise price
$138.07
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person.

Footnote F2

Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria.

Footnote F3

738 of the 2394 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting.

Footnote F4

Options vest 20% Year 1; 40% Year 2; and 40% Year 3.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .